Alethea Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,718
| Closed | -$370K | – | 26 |
|
|
2024
Q4 | $370K | Buy |
+3,718
| New | +$383K | 0.32% | 19 |
|
|
2024
Q1 | – | Sell |
-2,500
| Closed | -$273K | – | 50 |
|
|
2023
Q4 | $273K | Sell |
2,500
-3,203
| -56% | -$332K | 0.31% | 29 |
|
|
2023
Q3 | $587K | Sell |
5,703
-2,609
| -31% | -$281K | 0.72% | 6 |
|
|
2023
Q2 | $959K | Buy |
8,312
+4,312
| +108% | +$490K | 1.03% | 6 |
|
|
2023
Q1 | $426K | Hold |
4,000
| – | – | 0.45% | 30 |
|
|
2022
Q4 | $444K | Hold |
4,000
| – | – | 0.43% | 9 |
|
|
2022
Q3 | $344K | Hold |
4,000
| – | – | 0.43% | 19 |
|
|
2022
Q2 | $365K | Sell |
4,000
-9,565
| -71% | -$848K | 0.46% | 33 |
|
|
2022
Q1 | $1.11M | Buy |
13,565
+9,565
| +239% | +$754K | 1.01% | 9 |
|
|
2021
Q4 | $307K | Sell |
4,000
-300
| -7% | -$23.9K | 0.26% | 58 |
|
|
2021
Q3 | $323K | Hold |
4,300
| – | – | 0.28% | 58 |
|
|
2021
Q2 | $334K | Sell |
4,300
-206
| -5% | -$15.3K | 0.21% | 62 |
|
|
2021
Q1 | $331K | Buy |
4,506
+1,362
| +43% | +$100K | 0.2% | 62 |
|
|
2020
Q4 | $245K | Sell |
3,144
-8,288
| -72% | -$634K | 0.12% | 67 |
|
|
2020
Q3 | $905K | Buy |
11,432
+2,107
| +23% | +$165K | 0.61% | 20 |
|
|
2020
Q2 | $688K | Buy |
9,325
+6,181
| +197% | +$465K | 0.4% | 20 |
|
|
2020
Q1 | $231K | Hold |
3,144
| – | – | 0.15% | 71 |
|
|
2019
Q4 | $273K | Hold |
3,144
| – | – | 0.12% | 74 |
|
|
2019
Q3 | $253K | Hold |
3,144
| – | – | 0.16% | 73 |
|
|
2019
Q2 | $252K | Hold |
3,144
| – | – | 0.16% | 74 |
|
|
2019
Q1 | $250K | Sell |
3,144
-2,096
| -40% | -$157K | 0.18% | 65 |
|
|
2018
Q4 | $382K | Hold |
5,240
| – | – | 0.56% | 40 |
|
|
2018
Q3 | $355K | Hold |
5,240
| – | – | 0.53% | 59 |
|
|
2018
Q2 | $304K | Sell |
5,240
-5,567
| -52% | -$314K | 0.52% | 54 |
|
|
2018
Q1 | $562K | Buy |
10,807
+476
| +5% | +$25.7K | 0.76% | 32 |
|
|
2017
Q4 | $555K | Sell |
10,331
-419
| -4% | -$23.2K | 0.88% | 42 |
|
|
2017
Q3 | $657K | Hold |
10,750
| – | – | 0.77% | 38 |
|
|
2017
Q2 | $657K | Sell |
10,750
-20,831
| -66% | -$1.27M | 0.75% | 39 |
|
|
2017
Q1 | $1.92M | Buy |
31,581
+22,927
| +265% | +$1.39M | 2.3% | 18 |
|
|
2016
Q4 | $486K | Hold |
8,654
| – | – | 0.61% | 47 |
|
|
2016
Q3 | $453K | Hold |
8,654
| – | – | 0.63% | 44 |
|
|
2016
Q2 | $476K | Buy |
8,654
+1,048
| +14% | +$55.8K | 0.65% | 45 |
|
|
2016
Q1 | $384K | Sell |
7,606
-84
| -1% | -$4.11K | 0.43% | 48 |
|
|
2015
Q4 | $388K | Buy |
7,690
+65
| +0.9% | +$3.28K | 0.45% | 54 |
|
|
2015
Q3 | $359K | Buy |
7,625
+258
| +4% | +$13.7K | 0.55% | 51 |
|
|
2015
Q2 | $400K | Sell |
7,367
-212
| -3% | -$11.9K | 0.61% | 43 |
|
|
2015
Q1 | $416K | Buy |
7,579
+212
| +3% | +$12K | 0.46% | 47 |
|
|
2014
Q4 | $399K | Buy |
+7,367
| New | +$410K | 0.41% | 64 |
|
Other funds holding MRK
Alethea Capital Management's MRK Position: Q1 2025 in Review
Alethea Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 3,718 shares — an estimated $370K sold.
Alethea Capital Management first reported a position in MRK in Q4 2014 and held it in 38 quarters. The position peaked at $1.92M in Q1 2017. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Alethea Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
- Alethea Capital Management sold 3,718 Merck shares in Q1 2025, an estimated $370K.
- Alethea Capital Management first reported a position in Merck in Q4 2014 and held it in 38 quarters.
- Alethea Capital Management's Merck position peaked at $1.92M in Q1 2017.
- 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Alethea Capital Management's 13F filing for Q1 2025, filed 14 May 2025.